Acter Group Co., Ltd. (will be abbreviated “Acter” in the after, stock code: 5536) announces the revenue for March 2022. On a consolidated basis, revenues for March 2022 was NTD 2.4 billion and consecutive renew the same period record over the years compare to the same period of last year amounted to NTD 1.4 billion. The first quarterly consolidated revenue was 5.4 billion, renews the same period record over the years, and has a 50% growth compare to the same period of last year.

Acter indicates that following the terminal market application demand increase of 5G, AI, IoT, and vehicle use, the global chip market’s supply and demand become more unbalanced. Not only have various countries released policies to localize the semiconductors industry but also the international semiconductors continue to increase capital expenditure and aggressively expand produce capacity. On the trend of the global supply chain reconstruction, Acter’s multi-industries and multi-regions competitive advantage, sensor energy storage, electronic components, biotechnology industry, and high level business office project demands remain high level and push Acter’s cleanroom, electro-mechanical integration engineering and overall take orders present outstanding performance. Acter has renewed monthly revenue record for nine consecutive months and revenue for March and first quarterly revenue 2022 have a 74% and 50% growth, respectively.

Acter further indicates that Acter continuously extend the core skill service scale to aggressively integrate electro-mechanical engineering, cleanroom engineering, TURNKEY service and high technology process equipment, including Nova (Nova Technology Corp.) and Rayzher (Rayzher industrial Co. LTd.)’s gas, chemical supply system’s process engineering profession and hook up service, continue deepen cleanroom and electro-mechanical’s integration, factory service and process technology. Acter is deemed that capable to satisfy various service demands from multi-industries and remain well project quality and project process schedule. On the trend of global multi-industries large scale expansion, Acter’s multi-industries, multi-regions, and multi-type of engineering work business competitive advantage is helpful to create market competitive advantage and increase market value under a well industry prospect.

Looking forward to the second quarter of 2022, Acter takes a cautious and optimistic view. Acter still cautious deal with the epidemic effect from China area and closely concern the material price fluctuation effect from Russian-Ukrainian War, and speedily confirm the project cost after the project was confirmed. Using the highest level epidemic prevention measures to make sure continuous engineering service provide to clients, apply building information modeling largely reduce the project pipeline collision disturb, increase project process accuracy and quality, use the most efficiency allocation of material and project human resource, make sure the profit ability remain certain level, collaborate with university and college relative departments, aggressively build excellent human resource and well internal training to expand Acter’s take order capacity, and it’s helpful to create Acter’s bright future operation.

*The number is unaudited.

Acter 2022/03 Concise Consolidated Revenue Report：                         

Unit: NTD thousand；%

News Contact:

Acter Assistant Vice President  Miss Tsao  (04)2261-5288  IR@acter.com.tw